Cost-effectiveness of pharmaceutical management for osteoarthritis pain: a systematic review of the literature and recommendations for future economic evaluation.

Abstract:

BACKGROUND AND OBJECTIVE:Osteoarthritis (OA) is a highly prevalent and chronic condition characterized by pain and physical disability. Currently, many treatments are available, and they primarily target pain relief. The objectives of this study were to systematically review economic evaluations for pharmaceutical management of OA pain and to provide methodological recommendations for future economic evaluation. METHODS:Published literature was identified by searching the following bibliographic databases: MEDLINE (1948-16 November 2011) with In-Process records and EMBASE (1980-2011 Week 47) via Ovid; The Cochrane Library (Issue 4 of 4, 2011) and the Health Economic Evaluations Database (HEED) via Wiley; and PubMed (for non-MEDLINE records). The main search terms were OA and economic evaluations. Two reviewers independently screened all identified articles and extracted the data from those included in the final review. RESULTS:Twelve articles reporting the cost-effectiveness of various pharmaceuticals were included, with five being trial-based and seven being model-based economic evaluations. The mean health economics quality score of the included articles was 84 (minimum-maximum: 63-99). These evaluations varied in study design, treatments compared, and outcomes measured. CONCLUSION:The existing economic evaluations on pharmaceutical management of OA pain were of acceptable quality. Comparability of economic evaluations could be improved by selecting standard comparators, adopting a longer time horizon, and directly measuring health utilities.

journal_name

Drugs Aging

journal_title

Drugs & aging

authors

Xie F,Tanvejsilp P,Campbell K,Gaebel K

doi

10.1007/s40266-013-0062-3

subject

Has Abstract

pub_date

2013-05-01 00:00:00

pages

277-84

issue

5

eissn

1170-229X

issn

1179-1969

journal_volume

30

pub_type

杂志文章,评审
  • Melatonin prolonged release: in the treatment of insomnia in patients aged ≥55 years.

    abstract::Melatonin prolonged release (PR) 2 mg is approved for the treatment of primary insomnia characterized by poor sleep quality in patients aged ≥55 years in the EU and elsewhere. Patients may receive treatment with melatonin PR for up to 13 weeks. Production of endogenous nocturnal melatonin, which helps regulate circadi...

    journal_title:Drugs & aging

    pub_type: 杂志文章,评审

    doi:10.1007/s40266-012-0018-z

    authors: Lyseng-Williamson KA

    更新日期:2012-11-01 00:00:00

  • Evidence-Based Management of Diabetes in Older Adults.

    abstract::The number of older adults with diabetes is rapidly increasing worldwide. A variety of factors contribute to the age-related increase in the incidence of diabetes. The lack of empiric evidence in the field has limited the management guidelines to mostly expert opinion. Given uncertainty over the rate at which to lower...

    journal_title:Drugs & aging

    pub_type: 杂志文章,评审

    doi:10.1007/s40266-018-0598-3

    authors: Mooradian AD

    更新日期:2018-12-01 00:00:00

  • Suitable Use of Injectable Agents to Overcome Hypoglycemia Risk, Barriers, and Clinical Inertia in Community-Dwelling Older Adults with Type 2 Diabetes Mellitus.

    abstract::The management of type 2 diabetes mellitus in older adults requires a comprehensive understanding of the relationship between the disease (medical) and the functional, psychological/cognitive, and social geriatric domains, to individualize both glycemic targets and therapeutic approaches. Prevention of hypoglycemia is...

    journal_title:Drugs & aging

    pub_type: 杂志文章,评审

    doi:10.1007/s40266-019-00706-4

    authors: Valencia WM,Florez HJ,Palacio AM

    更新日期:2019-12-01 00:00:00

  • Idiopathic thrombocytopenic purpura: a retrospective analysis in 139 patients of the influence of age on the response to corticosteroids, splenectomy and danazol.

    abstract:OBJECTIVE:To review the influence of age on the response of patients with idiopathic thrombocytopenic purpura (ITP) to corticosteroids, splenectomy and danazol. METHODS:We retrospectively reviewed a cohort of 139 consecutively treated patients with ITP diagnosed between 1985 and 1994. In particular, we analysed the th...

    journal_title:Drugs & aging

    pub_type: 杂志文章,评审

    doi:10.2165/00002512-200320110-00005

    authors: Andrès E,Zimmer J,Noel E,Kaltenbach G,Koumarianou A,Maloisel F

    更新日期:2003-01-01 00:00:00

  • Immunogenicity and Safety of Intradermal Influenza Vaccine in the Elderly: A Meta-Analysis of Randomized Controlled Trials.

    abstract:INTRODUCTION:Immunosenescence makes the elderly more susceptible to influenza complications and less responsive to vaccination. An intradermal formulation (IDflu) is one of several strategies being investigated to increase the immunogenicity of influenza vaccines. OBJECTIVE:The overall goal of the study was to assess ...

    journal_title:Drugs & aging

    pub_type: 杂志文章,meta分析

    doi:10.1007/s40266-015-0303-8

    authors: Pileggi C,Mascaro V,Bianco A,Nobile CG,Pavia M

    更新日期:2015-10-01 00:00:00

  • Polypharmacy in Home Care in Europe: Cross-Sectional Data from the IBenC Study.

    abstract:BACKGROUND:Home care (HC) patients are characterized by a high level of complexity, which is reflected by the prevalence of multimorbidity and the correlated high drug consumption. This study assesses prevalence and factors associated with polypharmacy in a sample of HC patients in Europe. METHODS:We conducted a cross...

    journal_title:Drugs & aging

    pub_type: 杂志文章

    doi:10.1007/s40266-018-0521-y

    authors: Giovannini S,van der Roest HG,Carfì A,Finne-Soveri H,Garms-Homolová V,Declercq A,Jónsson PV,van Hout H,Vetrano DL,Gravina EM,Bernabei R,Onder G

    更新日期:2018-02-01 00:00:00

  • Potentially inappropriate prescribing of renally cleared drugs in elderly patients in community and aged care settings.

    abstract:BACKGROUND:Limited data are available on the prevalence of inappropriate prescribing of renally cleared drugs in elderly patients in Australia. OBJECTIVES:To quantify and compare the extent of inappropriate prescribing (defined as at least one drug prescribed in an excessive dose or when contraindicated with respect t...

    journal_title:Drugs & aging

    pub_type: 杂志文章

    doi:10.1007/s40266-015-0261-1

    authors: Khanal A,Peterson GM,Castelino RL,Jose MD

    更新日期:2015-05-01 00:00:00

  • Streptogramins and their potential role in geriatric medicine.

    abstract::Despite advances in antimicrobial chemotherapy over recent decades, morbidity and mortality secondary to infection continues to rise. In addition, the incidence of infection caused by resistant organisms has also increased. Concurrently, the elderly are living longer than prior generations, often with disabling chroni...

    journal_title:Drugs & aging

    pub_type: 杂志文章,评审

    doi:10.2165/00002512-199813060-00004

    authors: Lomaestro BM,Briceland LL

    更新日期:1998-12-01 00:00:00

  • Calcium sensitising agents in heart failure.

    abstract::Congestive heart failure (CHF) is a common cardiovascular disorder that is characterised, in part, by a decreased cardiac output reserve. Accordingly, there is ongoing interest in the role of positive inotropic agents (e.g. adrenergic agonists and phosphodiesterase type III inhibitors, which mediate their cardiovascul...

    journal_title:Drugs & aging

    pub_type: 杂志文章,评审

    doi:10.2165/00002512-199812030-00003

    authors: Mathew L,Katz SD

    更新日期:1998-03-01 00:00:00

  • Issues in the perioperative management of the elderly patient with cardiovascular disease.

    abstract::The elderly patient may show normal physiological changes of the cardiovascular and respiratory systems that accompany aging, as well as features of intrinsic cardiac disease. The latter include: a past history of myocardial infarction or ischaemic heart disease; history of congestive cardiac failure; angina; arterial...

    journal_title:Drugs & aging

    pub_type: 杂志文章,评审

    doi:10.2165/00002512-200219060-00003

    authors: Sear JW,Higham H

    更新日期:2002-01-01 00:00:00

  • Treatment of pruritus associated with systemic disorders in the elderly: a review of the role of new therapies.

    abstract::Generalised pruritus is common in the elderly. Idiopathic 'senile pruritus' is a diagnosis of exclusion, and an underlying systemic disorder should be sought. Thyroid disease, haematological malignancy, iron deficiency, cholestasis or renal impairment may be responsible for pruritus. Rarely pruritus may occur after ce...

    journal_title:Drugs & aging

    pub_type: 杂志文章,评审

    doi:10.2165/00002512-200320030-00004

    authors: Lonsdale-Eccles A,Carmichael AJ

    更新日期:2003-01-01 00:00:00

  • Effect of reproductive hormones and selective estrogen receptor modulators on mood during menopause.

    abstract::Periods of intense hormonal fluctuations have been associated with heightened prevalence and exacerbation of underlying psychiatric illness, particularly the occurrence of premenstrual dysphoria, puerperal depression and depressive symptoms during perimenopause. It has been speculated that sex steroids such as estroge...

    journal_title:Drugs & aging

    pub_type: 杂志文章,评审

    doi:10.2165/00002512-200320020-00001

    authors: Soares CN,Poitras JR,Prouty J

    更新日期:2003-01-01 00:00:00

  • Use of beta-adrenoceptor antagonists in older patients with chronic obstructive pulmonary disease and cardiovascular co-morbidity: safety issues.

    abstract::The incidence of and mortality from both chronic obstructive pulmonary disease (COPD) and cardiovascular disease (CVD) increase with age. In addition, the average age of patients with COPD and CVD is also increasing as a result of improvements in both pharmacological and non-pharmacological treatments. Coronary artery...

    journal_title:Drugs & aging

    pub_type: 杂志文章,评审

    doi:10.2165/00002512-200825020-00005

    authors: Andrus MR,Loyed JV

    更新日期:2008-01-01 00:00:00

  • The Internet as an information source for geriatricians.

    abstract::Electronic storage of and access to medical data is becoming increasingly common. Advances in computer technology and telecommunications have made it possible to store vast amounts of information in databases and transmit this information rapidly to any place on the globe. At the forefront of this technology is the In...

    journal_title:Drugs & aging

    pub_type: 杂志文章,评审

    doi:10.2165/00002512-199710030-00001

    authors: Glowniak J

    更新日期:1997-03-01 00:00:00

  • Diagnosis and treatment of dyspepsia in the elderly.

    abstract::Although dyspeptic symptoms are very common, the vast majority of patients have modest symptoms and rarely seek medical advice. The major organic causes of dyspepsia are chronic peptic ulcer disease, gastro-oesophageal reflux disease and malignancy. Functional dyspepsia is very common. In the fit elderly patient, prom...

    journal_title:Drugs & aging

    pub_type: 杂志文章,评审

    doi:10.2165/00002512-199507050-00003

    authors: Pound SE,Heading RC

    更新日期:1995-11-01 00:00:00

  • Cutaneous Drug Reactions in the Elderly.

    abstract::Cutaneous adverse drug reactions comprise a significant proportion of all adverse drug reactions. They may mimic other dermatologic or systemic illnesses and may cause significant morbidity or mortality. Seven morphologic groups encompass the most commonly encountered cutaneous drug reaction syndromes: exanthematous (...

    journal_title:Drugs & aging

    pub_type: 杂志文章,评审

    doi:10.1007/s40266-017-0483-5

    authors: Young JWS,Shear NH

    更新日期:2017-09-01 00:00:00

  • Stroke prevention in atrial fibrillation: putting the guidelines into practice.

    abstract::Atrial fibrillation confers a 5-fold increase in risk of stroke. A number of drugs aimed at reducing this risk have been tested in randomized controlled trials. These include antiplatelet agents (singly and in combination); anticoagulants, including vitamin K antagonists and direct thrombin inhibitors; and anticoagula...

    journal_title:Drugs & aging

    pub_type: 杂志文章,评审

    doi:10.2165/11538620-000000000-00000

    authors: Mant J,Edwards D

    更新日期:2010-11-01 00:00:00

  • Do we need drug therapy to manage mild hypertension in the elderly?

    abstract::Mild hypertension (grade 1 or stage 1 hypertension) is defined as a systolic blood pressure of 140-159 mm Hg or a diastolic pressure of 90-99 mm Hg. According to current guidelines, patients with mild hypertension can be at low, medium, high or very high risk depending on the presence of other risk factors, target org...

    journal_title:Drugs & aging

    pub_type: 杂志文章,评审

    doi:10.2165/00002512-200421010-00001

    authors: Fagard RH

    更新日期:2004-01-01 00:00:00

  • The economic burden of glaucoma and ocular hypertension: implications for patient management: a review.

    abstract::This paper reviews the burden and economic consequences of glaucoma upon healthcare systems and patients, especially elderly patients. An extensive review of the literature was conducted, primarily using MEDLINE, but also by examining selected article reference lists, relevant websites and the proceedings of specialis...

    journal_title:Drugs & aging

    pub_type: 杂志文章,评审

    doi:10.2165/00002512-200522040-00004

    authors: Rouland JF,Berdeaux G,Lafuma A

    更新日期:2005-01-01 00:00:00

  • The Perindopril Protection Against Recurrent Stroke Study (PROGRESS): clinical implications for older patients with cerebrovascular disease.

    abstract::Blood pressure levels are strongly predictive of the risks of first-ever and recurrent stroke. The benefits of blood pressure-lowering therapy for the prevention of fatal and non-fatal stroke in middle-aged individuals are well established. However, until recently, there has been uncertainty about the consistency of s...

    journal_title:Drugs & aging

    pub_type: 杂志文章,评审

    doi:10.2165/00002512-200320040-00001

    authors: Ratnasabapathy Y,Lawes CM,Anderson CS

    更新日期:2003-01-01 00:00:00

  • Effectiveness of Interventions to Deprescribe Inappropriate Proton Pump Inhibitors in Older Adults.

    abstract:BACKGROUND:The use of proton pump inhibitors (PPIs) in older adults is high, often inappropriate, and may cause harm. Deprescribing is defined as the reduction, withdrawal, or discontinuation of inappropriate medication. OBJECTIVE:We conducted a systematic review to determine the effectiveness of interventions to depr...

    journal_title:Drugs & aging

    pub_type: 杂志文章,评审

    doi:10.1007/s40266-017-0442-1

    authors: Wilsdon TD,Hendrix I,Thynne TR,Mangoni AA

    更新日期:2017-04-01 00:00:00

  • Quality measures for medication continuity in long-term care facilities, using a structured panel process.

    abstract:BACKGROUND:Patient transitions, such as transfers between acute and long-term care (LTC), aposare times when the likelihood of communication failure between healthcare providers is increased. Employing appropriate health quality indicators helps support improvement efforts. To date, few quality indicators that evaluate...

    journal_title:Drugs & aging

    pub_type: 杂志文章

    doi:10.2165/11599150-000000000-00000

    authors: Bell CM,Brener SS,Comrie R,Anderson GM,Bronskill SE

    更新日期:2012-04-01 00:00:00

  • Management of lipid disorders in the elderly.

    abstract::Cardiovascular disease has been inseparable from aging in developed societies and, as a result, it is the commonest cause of mortality in elderly populations. Atherosclerosis is associated with the progressive vascular accumulation of cholesterol-laden lipoproteins, and is linearly associated with the plasma level of ...

    journal_title:Drugs & aging

    pub_type: 杂志文章,评审

    doi:10.2165/00002512-199710060-00005

    authors: Playford DA,Watts GF

    更新日期:1997-06-01 00:00:00

  • Meglitinide analogues in the treatment of type 2 diabetes mellitus.

    abstract::Type 2 diabetes mellitus is a complex heterogenous metabolic disorder in which peripheral insulin resistance and impaired insulin release are the main pathogenetic factors. The rapid response of the pancreatic beta-cells to glucose is already markedly disturbed in the early stages of type 2 diabetes mellitus. The cons...

    journal_title:Drugs & aging

    pub_type: 杂志文章,评审

    doi:10.2165/00002512-200017050-00007

    authors: Landgraf R

    更新日期:2000-11-01 00:00:00

  • Factors influencing the implementation of quality use of medicines in residential aged care.

    abstract:BACKGROUND:In response to concerns about, and issues pertaining to, medication use practices in residential aged-care facilities (RACFs), the Australian Pharmaceutical Advisory Council (APAC) established a working party on quality use of medicines (QUM) in nursing homes and hostels. The APAC is a representative ministe...

    journal_title:Drugs & aging

    pub_type: 杂志文章,评审

    doi:10.2165/00002512-200421120-00005

    authors: Cheek J,Gilbert A,Ballantyne A,Penhall R

    更新日期:2004-01-01 00:00:00

  • Antihypertensive therapy in the aged patient. Clinical pharmacokinetic considerations.

    abstract::The incidence of both systolic and diastolic hypertension is increased in elderly patients, therefore antihypertensive drugs are commonly used in this population. In addition to changes in blood pressure, the aging process also causes numerous changes in other physiological parameters, resulting in altered pharmacokin...

    journal_title:Drugs & aging

    pub_type: 杂志文章,评审

    doi:10.2165/00002512-199101030-00004

    authors: Piepho RW,Fendler KJ

    更新日期:1991-05-01 00:00:00

  • Potential Statin Overuse in Older Patients: A Retrospective Cross-Sectional Study Using French Health Insurance Databases.

    abstract:BACKGROUND:Although compelling evidence exists supporting statins (HMG-CoA reductase inhibitors) for secondary prevention in older patients with clinical atherosclerotic diseases, the same cannot be said for primary prevention. OBJECTIVES:The objectives of this study were to estimate the frequency of potential statin ...

    journal_title:Drugs & aging

    pub_type: 杂志文章

    doi:10.1007/s40266-019-00695-4

    authors: Borne E,Meyer N,Rybarczyck-Vigouret MC,Blanchard O,Lombard M,Lang PO,Vogel T,Michel B

    更新日期:2019-10-01 00:00:00

  • Effect of antihypertensive agents on quality of life in the elderly.

    abstract::Management of hypertension in the elderly should take into account, in particular, the possible negative impact of antihypertensive drugs on the patient's quality of life, the deterioration of which may result in a loss of independence and reduced treatment compliance. Quality of life is recognised as a multifactorial...

    journal_title:Drugs & aging

    pub_type: 杂志文章,评审

    doi:10.2165/00002512-200421060-00003

    authors: Fogari R,Zoppi A

    更新日期:2004-01-01 00:00:00

  • Pharmacology and therapeutic effects of dehydroepiandrosterone in older subjects.

    abstract::Man and higher primates have adrenals that secrete large amounts of dehydroepiandrosterone (DHEA) [prasterone] and its sulphate (DHEAS) [PB 008]. A remarkable feature of plasma DHEAS levels in humans is their great decrease with aging. Researchers have postulated that this age-related decline of DHEAS levels may expla...

    journal_title:Drugs & aging

    pub_type: 杂志文章,评审

    doi:10.2165/00002512-200320130-00001

    authors: Legrain S,Girard L

    更新日期:2003-01-01 00:00:00

  • The Evolving Complexity of Treating Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor-2 (HER2)-Negative Breast Cancer: Special Considerations in Older Breast Cancer Patients-Part I: Early-Stage Disease.

    abstract::The median age for breast cancer diagnosis is 62 years, but a disproportionate number of patients are over the age of 75 years and the majority of those have hormone receptor-positive, human epidermal growth factor receptor-2 (HER2)-negative cancers. This review provides a logical algorithm to guide providers through ...

    journal_title:Drugs & aging

    pub_type: 杂志文章,评审

    doi:10.1007/s40266-020-00748-z

    authors: Sammons S,Sedrak MS,Kimmick GG

    更新日期:2020-05-01 00:00:00